Home Cart 0 Sign in  
X

[ CAS No. 615-20-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 615-20-3
Chemical Structure| 615-20-3
Chemical Structure| 615-20-3
Structure of 615-20-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 615-20-3 ]

Related Doc. of [ 615-20-3 ]

Alternatived Products of [ 615-20-3 ]

Product Details of [ 615-20-3 ]

CAS No. :615-20-3 MDL No. :MFCD00005776
Formula : C7H4ClNS Boiling Point : -
Linear Structure Formula :- InChI Key :BSQLQMLFTHJVKS-UHFFFAOYSA-N
M.W : 169.63 Pubchem ID :11987
Synonyms :

Calculated chemistry of [ 615-20-3 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 44.63
TPSA : 41.13 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.28 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.19
Log Po/w (XLOGP3) : 2.9
Log Po/w (WLOGP) : 2.95
Log Po/w (MLOGP) : 2.11
Log Po/w (SILICOS-IT) : 3.83
Consensus Log Po/w : 2.79

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.38
Solubility : 0.07 mg/ml ; 0.000412 mol/l
Class : Soluble
Log S (Ali) : -3.42
Solubility : 0.0639 mg/ml ; 0.000376 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.58
Solubility : 0.0447 mg/ml ; 0.000264 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.21

Safety of [ 615-20-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P501-P270-P264-P301+P312+P330 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 615-20-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 615-20-3 ]
  • Downstream synthetic route of [ 615-20-3 ]

[ 615-20-3 ] Synthesis Path-Upstream   1~31

  • 1
  • [ 615-20-3 ]
  • [ 615-21-4 ]
YieldReaction ConditionsOperation in experiment
93% With hydrazine hydrate In ethanol at 80℃; for 5 h; To a solution of 2-chlorobenzo[d]thiazole (0.169 g, 1 mmol) inethanol, N2H4H2O (80percent, 5 mmol) was dropwise added withrefluxing at 80 °C for 5 h. When cooled to room temperature, themixture was filtered, washed and recrystallized with ethanol. Thewhite solid thus obtained and dried under vacuum to get compound7 (0.154 g) in 93percent yield. 1H NMR (DMSO-d6, 600 MHz):δ(ppm): 9.01 (s, 1H), 7.68 (d, J 7.8 Hz, 1H), 7.32 (d, J 8.0 Hz, 1H),7.20 (t, J 7.6 Hz, 1H), 6.98 (t, J 7.5 Hz, 1H), 5.03 (s, 2H). 13C NMR(DMSO-d6, 151 MHz): δ (ppm): 174.4, 153.9, 130.9, 125.8, 121.4,120.7, 118.3 (Fig. S5).
Reference: [1] Journal of Heterocyclic Chemistry, 1988, vol. 25, p. 543 - 547
[2] Dyes and Pigments, 2017, vol. 146, p. 344 - 351
[3] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 22, p. 294
[4] Journal of the American Chemical Society, 1951, vol. 73, p. 4007,4009
[5] Pubbl. Ist. Chim. ind. Univ. Bologna, 1943, # 5, p. 3
[6] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 4, p. 1071 - 1074
[7] Patent: US2018/22716, 2018, A1, . Location in patent: Paragraph 0282
[8] Patent: US2073600, 1934, ,
  • 2
  • [ 615-20-3 ]
  • [ 615-21-4 ]
  • [ 1141-88-4 ]
Reference: [1] Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry, 1999, vol. 38, # 6, p. 639 - 640
  • 3
  • [ 95-16-9 ]
  • [ 615-20-3 ]
YieldReaction ConditionsOperation in experiment
88% With tetrachloromethane; sodium t-butanolate In N,N-dimethyl-formamide at 20℃; for 3 h; Benzothiazole (1 mmol, 135.9 mg),Carbon tetrachloride (1.1 mmol, 169.2 mg) was placed in a 10 mL round bottom flask.Add 5 mL of N,N-dimethylformamideSodium tert-butoxide (4.0 mmol, 384.4 mg),Stir at room temperature for 3 hours,TLC monitored the endpoint of the reaction.The mixture was poured into water and extracted with dichloromethane. The organic phase was collected and dried. The dichloromethane was removed by rotary evaporation to give the crude product.The crude product was subjected to silica gel column chromatography with petroleum ether and ethyl acetate as eluent (volume ratio = 30:1).2-Chlorobenzothiazole (brown oily liquid, 149.2 mg, yield 88percent) was obtained.
Reference: [1] Organic and Biomolecular Chemistry, 2018, vol. 16, # 6, p. 886 - 890
[2] Patent: CN107501023, 2017, A, . Location in patent: Paragraph 0063; 0064
[3] Organic Letters, 2009, vol. 11, # 2, p. 421 - 423
[4] Journal of Organic Chemistry, 2009, vol. 74, # 21, p. 8309 - 8313
[5] Chemische Berichte, 1880, vol. 13, p. 16
[6] Journal of Organometallic Chemistry, 1999, vol. 588, # 2, p. 155 - 159
[7] Journal of Organometallic Chemistry, 2000, vol. 601, # 2, p. 233 - 236
  • 4
  • [ 149-30-4 ]
  • [ 615-20-3 ]
YieldReaction ConditionsOperation in experiment
90%
Stage #1: at 20 - 25℃; for 0.25 h; Inert atmosphere
Stage #2: at 20 - 25℃; for 3 h; Inert atmosphere
General procedure: A mixture of the 2-mercaptobenzo[d]thiazole (>1 g, 1 equiv) and sul-furyl chloride (10 equiv) was stirred at 20–25 °C for 15 min. Next, H 2 O(2 equiv) was added and the mixture was stirred at 20–25 °C for anadditional 3 h. A sample was taken, quenched with MeCN/H 2 O (2:1)and analyzed by HPLC. After completion of the reaction, the mixturewas diluted with MeCN (5 volumes) and slowly quenched with H 2 O(20 volumes). The product precipitated from the aqueous solution.The solid was collected and washed with H 2 O. Drying under vacuumafforded the pure product. In the case of the liquid product 2-chloro-benzo[d]thiazole (13), the reaction mixture was extracted withEtOAc. The organic layer was then dried and concentrated to affordthe product as an oil.2-Chlorobenzo[d]thiazole (13)Yield: 3.30 g, 19.5 mmol (90percent); yellow oil.1 H NMR (400 MHz, DMSO-d 6 ): δ = 7.45–7.62 (m, 2 H), 7.96 (dd, J =8.07, 0.73 Hz, 1 H), 8.09 (dd, J = 7.89, 0.92 Hz, 1 H).13 C NMR (101 MHz, DMSO-d 6 ): δ = 122.81, 122.86, 126.49, 127.47,136.19, 150.91, 153.23. HRMS (ESI): m/z [M + H] + calcd for C 7 H 5 ClNS: 169.9831; found:169.9844.
36.1 g With hydrogenchloride; dihydrogen peroxide In water at 38℃; for 4 h; In a 500 ml reaction flask, 36.4 g of 2-mercaptobenzothiazole and 80 g of water were cast, 29.7 g of 30percent hydrochloric acid was added, the temperature was raised to 38 ° C,48.5g mass fraction of 20percent hydrogen peroxide was added dropwise, after the end of incubation was incubated dropwise to detect the bodyWhen the content of 2-mercaptobenzothiazole in the system is less than 0.2percent, hydrogen peroxide (about 4h)After the reaction was settled stratification,The upper oily liquid is 2 - chlorobenzothiazole crude,Finally, anhydrous 2 - chlorobenzothiazole dry crude product obtained2-Chlorobenzothiazole fine 36.1g.
Reference: [1] Synthesis (Germany), 2018, vol. 50, # 10, p. 2027 - 2032
[2] Bulletin of the Chemical Society of Japan, 1992, vol. 65, # 11, p. 3163 - 3173
[3] , 1965, vol. 1, p. 1702 - 1704[4] Zhurnal Organicheskoi Khimii, 1965, vol. 1, p. 1679 - 1682
[5] Synthetic Communications, 2007, vol. 37, # 12, p. 2039 - 2050
[6] Patent: CN107129484, 2017, A, . Location in patent: Paragraph 0019; 0014; 0015; 0016; 0017; 0018
  • 5
  • [ 136-95-8 ]
  • [ 615-20-3 ]
Reference: [1] Bioscience, Biotechnology, and Biochemistry, 1993, vol. 57, # 9, p. 1561 - 1562
[2] Bioorganic and Medicinal Chemistry, 2009, vol. 17, # 14, p. 5275 - 5284
[3] Chemistry - A European Journal, 2018, vol. 24, # 55, p. 14622 - 14626
[4] Organic Process Research and Development, 2017, vol. 21, # 1, p. 44 - 51
[5] Organic and Biomolecular Chemistry, 2013, vol. 11, # 7, p. 1103 - 1108
[6] Zhurnal Obshchei Khimii, 1937, vol. 7, p. 2813,2815[7] Chem. Zentralbl., 1938, vol. 109, # II, p. 3084
[8] Journal of the Chemical Society, 1930, p. 2190,2209
[9] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 14, p. 4022 - 4025
[10] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 9, p. 3044 - 3049
  • 6
  • [ 615-21-4 ]
  • [ 615-20-3 ]
YieldReaction ConditionsOperation in experiment
43% at 50℃; for 2 h; SOCl2 (8.4 mL, 13.8 g, 116 mmol) was heated to 50°C,and then treated with 2-hydrazinobenzothiazole, 14 (2.50 g,15.1 mmol), portionwise over 45 min. The reaction mixturewas heated at 50°C for 2 h, allowed to cool to room temperature,and was filtered. The filtrate was concentrated underreduced pressure, to provide 2-chlorobenzothiazole, 15 (1.10g, 43percent yield), which was used in the following step withoutfurther purification.
2.64 g at 50℃; for 2 h; General procedure: The substituted aniline (1eq.) and ammonium thiocyanate (2eq.) in 150mL glacial acetic acid were cooled in an ice bath and stirred mechanically. To the sulution, bromine (2eq.) in 25ml glacial acetic acid was added dropwise at such arate to keep the temperature below 10oC throughout the addition. Stirring was continued for additional 30 min after the bromine addition. The precipitate was collected and recrystallization from ethanol to give 2-aminobenzthiazoles. Then, the substituted 2-aminobenzthiazoles (1eq) in ethylene glycol were added hydrazine hydrate (2eq.) and hydrazine dihydrochloride (2eq). The mixture was heated at 140 oC for 2h. After cooling, the precipitate was filtered to give used directly for next step without further purification. Then, the hydrazino compound was added to thionyl chloride (1eq.) for 2h at 50 oC. After evaporated under reduced pressure, the residue was taken up in ethyl acetate and washed with 1 M NaHCO3 and brine each for twice. The organic layer was dried and evaporated to give the crude final product. The crude product was purified by silica gel column chromatography using PE-EA as an eluent.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2007, vol. 17, # 14, p. 4022 - 4025
[2] Letters in Organic Chemistry, 2018, vol. 15, # 5, p. 455 - 461
[3] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 9, p. 3044 - 3049
  • 7
  • [ 147-93-3 ]
  • [ 615-20-3 ]
Reference: [1] Synthetic Communications, 2004, vol. 34, # 4, p. 735 - 742
  • 8
  • [ 149-30-4 ]
  • [ 615-20-3 ]
Reference: [1] Pharmaceutical Bulletin, 1953, vol. 1, p. 319,321
[2] Zhurnal Obshchei Khimii, 1937, vol. 7, p. 2813,2815[3] Chem. Zentralbl., 1938, vol. 109, # II, p. 3084
[4] Patent: US1757930, 1927, ,
[5] Patent: US1923957, 1929, ,
[6] Patent: US2043948, 1933, ,
[7] Journal of Organic Chemistry, 1937, vol. 2, p. 148,153
[8] Journal of the American Chemical Society, 1946, vol. 68, p. 1666
[9] Patent: US2469697, 1946, ,
[10] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 17, p. 611
[11] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 17, p. 611
  • 9
  • [ 515-84-4 ]
  • [ 126507-54-8 ]
  • [ 615-20-3 ]
  • [ 32137-76-1 ]
Reference: [1] Journal of Organometallic Chemistry, 1999, vol. 588, # 2, p. 155 - 159
  • 10
  • [ 125602-94-0 ]
  • [ 615-20-3 ]
Reference: [1] Patent: US4929618, 1990, A,
  • 11
  • [ 103-72-0 ]
  • [ 615-20-3 ]
Reference: [1] Journal of the Chemical Society, 1925, vol. 127, p. 1488
[2] Chemische Berichte, 1879, vol. 12, p. 1128[3] Chemische Berichte, 1880, vol. 13, p. 10
  • 12
  • [ 1986-08-9 ]
  • [ 615-20-3 ]
Reference: [1] Journal of the Indian Chemical Society, 1982, vol. 59, # 8, p. 1004 - 1005
  • 13
  • [ 62-53-3 ]
  • [ 615-20-3 ]
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2012, vol. 22, # 9, p. 3044 - 3049
  • 14
  • [ 934-34-9 ]
  • [ 615-20-3 ]
Reference: [1] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 17, p. 611
[2] Fortschr. Teerfarbenfabr. Verw. Industriezweige, vol. 17, p. 611
  • 15
  • [ 120-78-5 ]
  • [ 615-20-3 ]
Reference: [1] Patent: US2043948, 1933, ,
[2] Kogyo Kagaku Zasshi, 1943, vol. 46, p. 679[3] Chem.Abstr., 1949, p. 2022
  • 16
  • [ 149-30-4 ]
  • [ 615-20-3 ]
  • [ 4074-77-5 ]
Reference: [1] Zhurnal Obshchei Khimii, 1937, vol. 7, p. 2813,2815[2] Chem. Zentralbl., 1938, vol. 109, # II, p. 3084
  • 17
  • [ 136-95-8 ]
  • [ 67-66-3 ]
  • [ 95-16-9 ]
  • [ 615-20-3 ]
  • [ 34263-66-6 ]
  • [ 2602-85-9 ]
Reference: [1] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
[2] Journal of Chemical Research, Miniprint, 1980, # 12, p. 4935 - 4953
  • 18
  • [ 75-15-0 ]
  • [ 62-53-3 ]
  • [ 615-20-3 ]
Reference: [1] Comptes Rendus des Seances de l'Academie des Sciences, Serie C: Sciences Chimiques, 1976, vol. 283, p. 319 - 321
  • 19
  • [ 76-02-8 ]
  • [ 126507-54-8 ]
  • [ 41268-26-2 ]
  • [ 615-20-3 ]
  • [ 4271-09-4 ]
Reference: [1] Journal of Organometallic Chemistry, 1999, vol. 588, # 2, p. 155 - 159
  • 20
  • [ 95-16-9 ]
  • [ 10026-13-8 ]
  • [ 615-20-3 ]
Reference: [1] Chemische Berichte, 1880, vol. 13, p. 16
  • 21
  • [ 10026-13-8 ]
  • [ 103-72-0 ]
  • [ 615-20-3 ]
  • [ 622-44-6 ]
Reference: [1] Chemische Berichte, 1879, vol. 12, p. 1128[2] Chemische Berichte, 1880, vol. 13, p. 10
  • 22
  • [ 615-20-3 ]
  • [ 2406-90-8 ]
Reference: [1] Antimicrobial agents and chemotherapy, 2002, vol. 46, # 8, p. 2588 - 2594
[2] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 14, p. 3328 - 3332
[3] Chemical Communications, 2013, vol. 49, # 77, p. 8644 - 8646
  • 23
  • [ 615-20-3 ]
  • [ 80945-86-4 ]
Reference: [1] Bollettino Scientifico della Facolta di Chimica Industriale di Bologna, 1943, vol. 4, # 1, p. 67[2] Gazzetta Chimica Italiana, 1948, vol. 78, p. 462,468
  • 24
  • [ 615-20-3 ]
  • [ 62266-82-4 ]
Reference: [1] Bollettino Scientifico della Facolta di Chimica Industriale di Bologna, 1944, vol. 5, p. 11,14, 16, 18
  • 25
  • [ 615-20-3 ]
  • [ 2407-11-6 ]
YieldReaction ConditionsOperation in experiment
87%
Stage #1: With sulfuric acid In water at 10 - 17℃; for 1.5 h;
Stage #2: With potassium nitrate In water at 12 - 40℃;
Step l1.088 g (6.42 mmol) of 2-chlorobenzothiazole and 8.56 ml of sulfuric acid were placed in a 50 niL flask, followed by keeping the mixture at 10-17°C for 1.5 hrs. After observing that the color of the reaction mixture was white, the reaction mixture was cooled to 12°C, 714 mg (7.062 mmol) of potassium nitrate was added thtereto, and the resulting mixture was stirred with maintaining the reaction temperature less than 18 °C for 1 hr. The resulting solution was heated to 25 °C , stirred for 1.5 hrs, and slowly heated to 40 "C . After confirming the completion of the reaction by TLC, the resulting mixture was cooled to room temperature and poured into ice water, and the resulting solid was filtered, washed with water (until pH is 7), and dried under a vacuum condition to obtain 2-chloro-6-nitrobenzothiazole (yield: 87percent).
82% at 0 - 20℃; for 18.5 h; 2-Chloro-1,3-benzothiazole (16, 10.0 g, 58.95 mmol) was addedportion wise to concentrated H2SO4(60 mL) in a cooled roundbottomed flask (ice bath). Potassium nitrate (6.56 g,64.85 mmol)was added portion wise, and the resulting reaction mixture was stirred at 0 °C (ice bath) for 30 min, and then atroom temperature for 18 h. The solution was poured onto iceand the formed precipitate collected by filtration. The collectedsolid was rinsed with ice cold water until acid free, and thendried under reduced pressure. The crude product was furtherpurified by recrystallisation from MeCN (≈100 mL) or EtOH(≈425 mL)to yield 6as fine off-white needles. Yield fromEtOH (10.37 g, 48.34 mmol, 82percent), from MeCN (9.21 g, 42.89mmol, 73percent). Mp 193–194 °C (EtOH); 1H NMR (500 MHz,CDCl3) δ8.75 (d, J= 2.3 Hz, 1H, CH-7), 8.38 (dd, J= 9.0, 2.3Hz, 1H, CH-5), 8.07 (d, J= 9.0 Hz, 1H, CH-4); 13C NMR (125MHz, CDCl3) δ158.9 (C-2), 154.9 (C-6), 145.6 (C-7a), 136.6(C-3a), 123.5 (CH-4), 122.4 (CH-5), 117.8 (CH-7).
64% at 0℃; for 1 h; 2-chlorobenzothiazole (8.0 g, 47.16 mmol) placed in a 100 mL ofthree-necked flask was added by concentrated H2SO4 (40mL) carefully under 0 0C. At 0 0C KNO3 (5.0 g,49.52 mmol) was added portionwise and kept stirring for 1 hour. The mixture wasthen poured into ice-water (100 mL). The precipitate was collected, washed withNaHCO3 solution, dissolved into 200 mL of DCM, dried over Na2SO4and triturated by EtOH (80 mL) to get the desired product as light yellowsolid. (6.5 g, 64percent yield)LC-MS (ESI):no mass observed, tR = 3.90 min.1H NMR (400 MHz, CDCl3)δ 8.75 (s, 1H), 8.38 (d, J = 9.0 Hz, 1H), 8.07 (d, J = 8.9 Hz,1H).13C NMR (101 MHz, CDCl3)δ 158.77, 154.75, 145.43, 136.47, 123.33, 122.24, 117.69.
58% at 0 - 5℃; for 3.33333 h; To a solution of 2-chlorobenzothiazole (1.20g, 7.07 mmol) in concentrated H2SO4 (6 mL) was addedHNO3 (69percent solution, 0.6 mL) dropwise at 0 °C for 20 min.The mixture was stirred at 5 °C for 3 h, poured in ice-water.The precipitate was collected and washed 5percent sodiumbicarbonate and water, dried in vacuo.
49% at 0 - 20℃; for 1.5 h; (A)
Synthesis of 2-chloro-6-nitrobenzothiazole (2)
Compound 1 (25.1 g, 147 mmol) was added dropwise to concentrated sulfuric acid (135 mL) under ice cooling, then potassium nitrate (16.4 g, 162 mmol) was added to the mixture.
The mixture was stirred under ice cooling as it was for 30 minutes, and then stirred at room temperature for 1 hour.
The reaction mixture was poured into ice water, and the precipitates were separated by filtration and washed with water.
The precipitates were recrystallized from ethanol to obtain Compound 2 as white acicular crystals (15.6 g, 49percent yield).
1H-NMR (300 MHz, CDCl3) δ 8.07 (d, 1H, J=8.9 Hz), 8.39 (dd, 1H, J=2.2, 8.9 Hz) 8.75 (d, 1H, J=2.2 Hz). MS (EI+) 214, M+.

Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2005, vol. 15, # 14, p. 3328 - 3332
[2] Advanced Synthesis and Catalysis, 2017, vol. 359, # 11, p. 1837 - 1843
[3] Patent: WO2008/153325, 2008, A1, . Location in patent: Page/Page column 36
[4] Beilstein Journal of Organic Chemistry, 2016, vol. 12, p. 2019 - 2025
[5] Farmaco, 1994, vol. 49, # 3, p. 153 - 166
[6] Journal of the American Chemical Society, 2010, vol. 132, # 39, p. 13586 - 13587
[7] Chemical Communications, 2013, vol. 49, # 77, p. 8644 - 8646
[8] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 24, p. 7661 - 7670
[9] Bulletin of the Korean Chemical Society, 2013, vol. 34, # 2, p. 495 - 499
[10] Patent: US2007/155806, 2007, A1, . Location in patent: Page/Page column 5
[11] Chemistry - An Asian Journal, 2011, vol. 6, # 7, p. 1800 - 1810
[12] Chemische Berichte, 1880, vol. 13, p. 10
[13] Antimicrobial agents and chemotherapy, 2002, vol. 46, # 8, p. 2588 - 2594
[14] Patent: US5475014, 1995, A,
[15] Patent: EP1308439, 2003, A1,
[16] Mutation Research - Genetic Toxicology and Environmental Mutagenesis, 2008, vol. 650, # 2, p. 104 - 114
[17] Chemical Science, 2017, vol. 8, # 2, p. 1511 - 1524
  • 26
  • [ 615-20-3 ]
  • [ 3622-38-6 ]
  • [ 2407-11-6 ]
YieldReaction ConditionsOperation in experiment
72% With sulfuric acid; nitric acid In water at 0 - 5℃; for 3.33333 h; To a solution of 2-CHLOROBENZOTHIAZOLE (12.0 g, 70.7 MMOL) in concentrated H2SO4 (60 mL) was added HN03 (69percent solution, 6 mL) dropwise at 0°C for 20 min. The mixture was stirred at 5°C for 3h, poured into ice-water (150 mL). The precipitate was collected and washed with 5percent sodium bicarbonate and water, dried in VACUO.APOS;H NMR analysis showed the mixture contained 78percent 6-nitro-2-chlorobenzothiazole and 8percent 5-nitro-2- chlorobenzothiazole. Recrystallization from ethanol gave 6-nitro-2-chlorobenzothiazole as white crystalline solid (11 g, 72percent). 3.5 g of the solid was dissolved in refluxing ethanol-acetic acid (150: 15 mL), Iron powder was added in one portion.. The mixture was refluxed for 1.5h, filtered. The filtrate was concentrated in vacuo to half volume and neutralized with 10percent NaOH to pH 7.5, extracted with ethyl acetate. The organic phase was washed with brine, dried over magnesium sulphate and evaporated to give a residue, which was RECRYSTALLIZED from ethanol. Light purple crystals (2.5 g, 83percent) were obtained. Mp 160-164°C ; TLC single spot at Rf 0.27 (30percent EtOAc/hexane) ;APOS;HNMR (270 MHz, DMSO-d6) 5 7.58 (1H, d, J = 9.0 Hz, 4-H), 7.03 (1H, d, J = 2.0 Hz, 7-H), 6.77 (1 H, dd, J = 9.0, 2. 0 Hz, 5-H), 5.55 (2H, s, NH2). The mother liquor from the RECRYSTALLIZATION of nitration product was evaporated and subjected to iron powder reduction as described above. The crude product was purified with flash chromatography (ethyl acetate-DCM gradient elution) to give 2-CHLORO- benzothiazol-5-yl-amine as yellow solid. Mp 146-149°C ; TLC single spot at Rf 0.52 (10percent EtOAc/DCM) ;APOS;HNMR (270 MHZ, DMSO-d6) 8 7.63 (1 H, d, J = 8. 6 HZ, 7-H), 7.05 (1 H, d, J = 2.3 Hz, 4-H), 6.78 (1 H, dd, J = 8.6, 2.3 Hz, 6-H), 5.40 (2H, s, NH2).
Reference: [1] Patent: WO2004/37251, 2004, A1, . Location in patent: Page/Page column 99; 100
  • 27
  • [ 615-20-3 ]
  • [ 2942-22-5 ]
  • [ 2407-11-6 ]
  • [ 3507-30-0 ]
YieldReaction ConditionsOperation in experiment
8% at 0℃; for 1 h; To a flask was added cone. H2SO4 (30 mL) and cone. HNO3 (15 mL) slowly at0 0C, then 2-chloro-benzothiazole (5.0 g, 29.5 mmol) was added dropwise. After stirring at 0 0C for 1 hr, the mixture was poured into ice slowly. After being warmed to room temperature, the solid was collected by filtration, washed with water, air dried, then purified by flash chromatography (silica gel, DCM:hexane/5:5) to afford 0.51 g (8percent) of 2-chloro-4-nitro-benzothiazole Compound Ia, 3.92 g (62percent) of 2-chloro-6- nitro-benzothiazole Compound Ib and 1.46 g (23percent) of 2-chloro-7-nitro-benzothiazole Compound Ic. Alternatively, Compound Ia, Compound Ib and Compound Ic are commercially available.Compound Ia: 1H NMR (400 MHz, CDCl3) δ 8.20 (d, J= 7.9 Hz, 1 H), 8.04 (d, J= 8.0, 1 H), 7.57 (t, J= 7.9 Hz, 1 H). MS (ESI) m/z: 215 (M+H)+.Compound Ib: 1H NMR (400 MHz, CDCl3) δ 8.78 (s, 1 H), 8.35 (d, J= 8.3 Hz,1 H), 8.05 (d, J= 8.4 Hz, 1 H). MS (ESI) m/z: 215 (M+H)+.Compound Ic: 1H NMR (400 MHz, CDCl3) δ 8.42 (d, J= 7.9 Hz, 1 H), 8.29 (d, J= 8.0 Hz, 1 H), 7.70 (t, J= 8.0 Hz, 1 H). MS (ESI) m/z: 215 (M+H)+.
Reference: [1] Patent: WO2007/121154, 2007, A2, . Location in patent: Page/Page column 38
  • 28
  • [ 615-20-3 ]
  • [ 1123-99-5 ]
Reference: [1] Journal of Organic Chemistry, 2011, vol. 76, # 21, p. 8726 - 8736
  • 29
  • [ 615-20-3 ]
  • [ 2942-22-5 ]
  • [ 2407-11-6 ]
  • [ 3507-30-0 ]
YieldReaction ConditionsOperation in experiment
8% at 0℃; for 1 h; To a flask was added cone. H2SO4 (30 mL) and cone. HNO3 (15 mL) slowly at0 0C, then 2-chloro-benzothiazole (5.0 g, 29.5 mmol) was added dropwise. After stirring at 0 0C for 1 hr, the mixture was poured into ice slowly. After being warmed to room temperature, the solid was collected by filtration, washed with water, air dried, then purified by flash chromatography (silica gel, DCM:hexane/5:5) to afford 0.51 g (8percent) of 2-chloro-4-nitro-benzothiazole Compound Ia, 3.92 g (62percent) of 2-chloro-6- nitro-benzothiazole Compound Ib and 1.46 g (23percent) of 2-chloro-7-nitro-benzothiazole Compound Ic. Alternatively, Compound Ia, Compound Ib and Compound Ic are commercially available.Compound Ia: 1H NMR (400 MHz, CDCl3) δ 8.20 (d, J= 7.9 Hz, 1 H), 8.04 (d, J= 8.0, 1 H), 7.57 (t, J= 7.9 Hz, 1 H). MS (ESI) m/z: 215 (M+H)+.Compound Ib: 1H NMR (400 MHz, CDCl3) δ 8.78 (s, 1 H), 8.35 (d, J= 8.3 Hz,1 H), 8.05 (d, J= 8.4 Hz, 1 H). MS (ESI) m/z: 215 (M+H)+.Compound Ic: 1H NMR (400 MHz, CDCl3) δ 8.42 (d, J= 7.9 Hz, 1 H), 8.29 (d, J= 8.0 Hz, 1 H), 7.70 (t, J= 8.0 Hz, 1 H). MS (ESI) m/z: 215 (M+H)+.
Reference: [1] Patent: WO2007/121154, 2007, A2, . Location in patent: Page/Page column 38
  • 30
  • [ 615-20-3 ]
  • [ 3622-38-6 ]
  • [ 2407-11-6 ]
YieldReaction ConditionsOperation in experiment
72% With sulfuric acid; nitric acid In water at 0 - 5℃; for 3.33333 h; To a solution of 2-CHLOROBENZOTHIAZOLE (12.0 g, 70.7 MMOL) in concentrated H2SO4 (60 mL) was added HN03 (69percent solution, 6 mL) dropwise at 0°C for 20 min. The mixture was stirred at 5°C for 3h, poured into ice-water (150 mL). The precipitate was collected and washed with 5percent sodium bicarbonate and water, dried in VACUO.APOS;H NMR analysis showed the mixture contained 78percent 6-nitro-2-chlorobenzothiazole and 8percent 5-nitro-2- chlorobenzothiazole. Recrystallization from ethanol gave 6-nitro-2-chlorobenzothiazole as white crystalline solid (11 g, 72percent). 3.5 g of the solid was dissolved in refluxing ethanol-acetic acid (150: 15 mL), Iron powder was added in one portion.. The mixture was refluxed for 1.5h, filtered. The filtrate was concentrated in vacuo to half volume and neutralized with 10percent NaOH to pH 7.5, extracted with ethyl acetate. The organic phase was washed with brine, dried over magnesium sulphate and evaporated to give a residue, which was RECRYSTALLIZED from ethanol. Light purple crystals (2.5 g, 83percent) were obtained. Mp 160-164°C ; TLC single spot at Rf 0.27 (30percent EtOAc/hexane) ;APOS;HNMR (270 MHz, DMSO-d6) 5 7.58 (1H, d, J = 9.0 Hz, 4-H), 7.03 (1H, d, J = 2.0 Hz, 7-H), 6.77 (1 H, dd, J = 9.0, 2. 0 Hz, 5-H), 5.55 (2H, s, NH2). The mother liquor from the RECRYSTALLIZATION of nitration product was evaporated and subjected to iron powder reduction as described above. The crude product was purified with flash chromatography (ethyl acetate-DCM gradient elution) to give 2-CHLORO- benzothiazol-5-yl-amine as yellow solid. Mp 146-149°C ; TLC single spot at Rf 0.52 (10percent EtOAc/DCM) ;APOS;HNMR (270 MHZ, DMSO-d6) 8 7.63 (1 H, d, J = 8. 6 HZ, 7-H), 7.05 (1 H, d, J = 2.3 Hz, 4-H), 6.78 (1 H, dd, J = 8.6, 2.3 Hz, 6-H), 5.40 (2H, s, NH2).
Reference: [1] Patent: WO2004/37251, 2004, A1, . Location in patent: Page/Page column 99; 100
  • 31
  • [ 615-20-3 ]
  • [ 7724-12-1 ]
Reference: [1] Chemistry - An Asian Journal, 2011, vol. 6, # 7, p. 1800 - 1810
[2] Chemical Communications, 2013, vol. 49, # 77, p. 8644 - 8646
[3] Beilstein Journal of Organic Chemistry, 2016, vol. 12, p. 2019 - 2025
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 615-20-3 ]

Chlorides

Chemical Structure| 80945-82-0

[ 80945-82-0 ]

5-Amino-2-chlorobenzothiazole

Similarity: 0.99

Chemical Structure| 3622-23-9

[ 3622-23-9 ]

2,6-Dichloro-1,3-benzothiazole

Similarity: 0.89

Chemical Structure| 154327-27-2

[ 154327-27-2 ]

2-Chloro-5-fluorobenzo[d]thiazole

Similarity: 0.87

Chemical Structure| 2406-90-8

[ 2406-90-8 ]

2-Chlorobenzo[d]thiazol-6-amine

Similarity: 0.86

Chemical Structure| 80945-86-4

[ 80945-86-4 ]

6-Bromo-2-chlorobenzothiazole

Similarity: 0.86